Cargando…

Estimating Mortality in Patients with Hematological Malignancy and COVID-19: A Pooled Analysis of 10 Studies

Patients with COVID-19 and underlying hematological malignancy seem to have a higher mortality rate compared with those patients without malignancy, however, the extent of such excess risk is unclear. We performed a systematic review of literature and a pooled analysis to provide precise estimates o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saini, Kamal S., Tagliamento, Marco, Lambertini, Matteo, McNally, Richard, Kelly, Adrianne, Romano, Marco, Chico, Isagani, Jenson, Taylor, Anderson, Steven M, Curigliano, Giuseppe, de Azambuja, Evandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	901.Health Services Research-Non-Malignant Conditions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330307/ http://dx.doi.org/10.1182/blood-2020-141749

Ejemplares similares

Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies
por: Saini, Kamal S., et al.
Publicado: (2020)

Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies
por: Behrens, Elizabeth, et al.
Publicado: (2020)

An Online Case-Based Clinical Elective in Hematology for Medical Students
por: Means, Robert T.
Publicado: (2020)

COVID-19 in Patients with Hematologic Malignancies: A Single-Center Experience
por: Wilde, Lindsay, et al.
Publicado: (2020)

Success and Satisfaction with Virtual Hematology Curriculum Implemented in Response to COVID-19
por: Gunesch, Ali Noel, et al.
Publicado: (2021)

The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives
por: Velazquez Manana, Ana I., et al.
Publicado: (2020)

Measuring the Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment
por: Durani, Urshila, et al.
Publicado: (2020)

COVID-19 Prognostic Score Utilizing Hematological and Inflammatory Markers to Determine Outcomes of Hospitalized Patients
por: Kalsi, Amardeep, et al.
Publicado: (2020)

Digital Platform for Evidence-Based Medicine in Hematology (non-malignant and malignant conditions) in a Developing Country
por: Rocha, Juliana, et al.
Publicado: (2020)

Impact on Mental Health, Disease Management and Socioeconomic Modifications in Hematological Patients during COVID-19 Pandemia in Italy
por: De Muro, Marianna, et al.
Publicado: (2020)

Perception and Psychological Help Seeking Behaviour Among Hematology Healthcare Workers during the COVID19 Pandemic in India
por: Prabha, Lakshmi, et al.
Publicado: (2020)

Environmental Sars-Cov-2 Surface Testing: Low Incidence of Virus Positivity in Outpatient and Inpatient Hematology/Oncology Settings
por: Shah, Mansi R, et al.
Publicado: (2020)

Social Media Validation for Pre-Screened Ontologies As a Driver for Biomolecular Interaction Significance in COVID-19 and Hematological Malignancies
por: Leyfman, Yan, et al.
Publicado: (2021)

Mental Health Assessment of Youth with Sickle Cell Disease and Their Primary Caretakers: Baseline Depression and COVID-19 Pandemic-Associated Psychosocial Stress in a Multi-Site Study
por: Green, Nancy S., et al.
Publicado: (2020)

Utilization of Telemedicine for Comprehensive Visits in Patients with Inherited Bleeding Disorders during the COVID-19 Pandemic
por: Wang, Cassandra P, et al.
Publicado: (2020)

COVID-19 Pandemic Highlights Health Disparities in Latinos in San Diego
por: Quiroz, Elisa, et al.
Publicado: (2020)

Influenza Vaccination in Asplenia: Improving Quality of Care in Time of Coronavirus
por: Di Maio, Nicoletta, et al.
Publicado: (2020)

COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait
por: Singh, Ashima, et al.
Publicado: (2020)

Impact of the COVID19 Pandemic on Admissions and Emergency Department Visits of Adults with Sickle Cell Disease
por: Cohen, Alice J.
Publicado: (2020)

Impact of a National Lockdown for COVID-19 on Morbidity and Mortality Among Children with Sickle Cell Anaemia at a Tertiary Care Hospital in Uganda
por: Namazzi, Ruth, et al.
Publicado: (2020)

Association of Anticoagulant Use with COVID-19 Diagnosis
por: Kavecansky, Juraj, et al.
Publicado: (2020)

COVID Symptoms and COVID Anxiety in Sickle Cell Disease
por: Smith, Wally R, et al.
Publicado: (2020)

Prospective Multicentric Observational Study of COVID19 in Oncohematological Patients in the Catalonia Region: The Opposite Effect of Steroids on Survival
por: Mussetti, Alberto, et al.
Publicado: (2020)

Critical Telehealth and Healthcare Utilization during COVID-19 in Sickle Cell Disease: CBO Reach in Understanding the Patient Experience
por: Fields, Jennifer, et al.
Publicado: (2020)

Clinical Impact of COVID-19 on Anticoagulation Management at the William S. Middleton Memorial Veterans Hospital
por: Hecht, Hannah, et al.
Publicado: (2020)

Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients
por: Palmer, Jeanne M., et al.
Publicado: (2020)

Incidence of Venous Thromboembolic Events in Hospitalized COVID-19 Patients: A Systematic Review
por: Galllastegui Crestani, Nicolas, et al.
Publicado: (2020)

Covid-19 Disease Is Not Associated with Venous Thromboembolism in a Cohort of Patients in Jeddah, Saudi Arabia
por: Kamel, Fatemah, et al.
Publicado: (2020)

Impact of COVID 19 Pandemic on Health Care Utilization for Patients with Sickle Cell Disease - a Specialty Treatment Center Experience
por: Jain, Akshat, et al.
Publicado: (2021)

For Better or for Worse: COVID-19 Vaccination during or Early after (Immuno-) Chemotherapy or Hematopoietic Progenitor Cell Transplantation
por: Haggenburg, Sabine, et al.
Publicado: (2021)

Effects of the COVID-19 Pandemic on Caregivers of Young Children with Sickle Cell Disease Enrolled in the Engage-HU Trial
por: Hood, Anna M, et al.
Publicado: (2021)

Drepadom - Establishment of Home Care Services and Hospitalizations for Sickle Cell Disease Patients As Standard Care Since the Covid-19 Pandemic
por: Pelinski, Yanís, et al.
Publicado: (2021)

The Telemedicine Experience for Individuals with Sickle Cell Disease
por: Weiss, Sara, et al.
Publicado: (2021)

Complete Blood Count Parameters Outperform Putative Inflammatory Markers in Predicting COVID-19 Mortality: A Multimodal Machine Learning Model
por: Idogun, Precious, et al.
Publicado: (2021)

Emerging issues related to COVID-19 vaccination in patients with cancer
por: Saini, Kamal S., et al.
Publicado: (2021)

Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece
por: Spyridis, Nikolaos, et al.
Publicado: (2021)

FRAÇÃO PLAQUETÁRIA IMATURA (IPF) COMO PARÂMETRO DE COAGULAÇÃO EM PACIENTES COM COVID-19: UM ESTUDO PROSPECTIVO
por: Cruz, L.A., et al.
Publicado: (2020)

Assessment of Hematologic and Coagulation Parameters As Predictive Value in COVID-19 with Unfavourable Evolution
por: Popov, Viola Maria, et al.
Publicado: (2020)

Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry
por: Gavrilina, Olga A., et al.
Publicado: (2020)

Final Results of CHRONOS19 Observational Study in Patients with Hematologic Disease and COVID-19 in Russia
por: Gavrilina, Olga A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4dnksc5bofu90hhmbfcu88ocvl